ABT (Abbott Laboratories) ROCE %: 8.00% (As of Mar. 2026)


ABT Abbott Laboratories ABT
80 GF Score
Price $90.49
GF Value $129.49
Valuation Significantly Undervalued
View Full Analysis

What is Abbott Laboratories ROCE %?

Abbott Laboratories ABT -0.04% 80 ROCE % is 8.00% as of Mar. 2026. GuruFocus rates ABT with a GF Score™ of 80/100 and a GF Value™ of $129.49 (Significantly Undervalued).

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Abbott Laboratories's annualized ROCE % for the quarter that ended in Mar. 2026 was 8.00%.

Abbott Laboratories  (NYSE:ABT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Abbott Laboratories ROCE % Related Terms

Abbott Laboratories ROCE % Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories ROCE % Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.25 14.65 12.34 11.96 13.03

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.25 13.07 13.13 14.18 8.00
ABT
80GF Score
Abbott Laboratories ABT
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories ROCE % Calculation

Abbott Laboratories's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=8959/( ( (81414 - 14157) + (86713 - 16496) )/ 2 )
=8959/( (67257+70217)/ 2 )
=8959/68737
=13.03 %

Abbott Laboratories's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=6492/( ( (86713 - 16496) + (110429 - 18377) )/ 2 )
=6492/( ( 70217 + 92052 )/ 2 )
=6492/81134.5
=8.00 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 8.00% mean?
Abbott Laboratories (ABT) has a ROCE % of 8.00% as of Mar. 2026.
Is Abbott Laboratories' ROCE % too high?
Abbott Laboratories' current ROCE % is 8.00%. The Medical Devices & Instruments industry median ROCE % is 2.23. Abbott Laboratories' value of 8.00% is 258.7% above this industry median. Overall, Abbott Laboratories has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' ROCE % compare to SYK and MDT?
Abbott Laboratories' ROCE % of 8.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Abbott Laboratories' value of 8.00% is 258.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current ROCE % of 8.00% is 258.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current ROCE % is 8.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (ABT) is currently considered Significantly Undervalued. The stock's GF Value™ is $129.49, compared to a current price of $90.49 — trading 30.1% below its estimated fair value. The current ROCE % is 8.00% and 258.7% above the Medical Devices & Instruments industry median of 2.23. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Abbott Laboratories (ABT), the current ROCE % is 8.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of $90.49 is trading 30.1% below its estimated GF Value™ of $129.49. GuruFocus considers Abbott Laboratories to be Significantly Undervalued.

Key valuation signals for ABT:

  • ROCE %: 8.00%
  • GF Value™: $129.49 vs. price of $90.49 (30.1% below fair value)
  • GF Score™: 80/100
  • Industry Position: 258.7% above the Medical Devices & Instruments median

No single metric tells the full story. See the ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for ABT

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$90.49
Price
$129.49
GF Value